We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 2,261

How often will the FTC use its recently reaffirmed authority to compel disgorgement?
  • K&L Gates
  • USA
  • September 6 2018

The U.S. District Court for the Eastern District of Pennsylvania recently granted the Federal Trade Commission’s (“FTC”) request to compel a branded


Federal Circuit Affirms Tribal Sovereign Immunity Does Not Apply to IPR
  • Marshall Gerstein & Borun LLP
  • USA
  • August 9 2018

The Federal Circuit recently affirmed the PTAB’s decision that tribal immunity cannot be asserted in an IPR (Saint Regis Mohawk Tribe v. Mylan Pharma


PTAB Upholds GILENYA Method of Treatment Patent, Prompting New ANDA Litigation
  • Jones Day
  • USA
  • July 30 2018

In Apotex Inc. v. Novartis AG, IPR2017-00854, Paper 109 (Jul. 11, 2018), the PTAB held that the claims of U.S. Patent No. 9,187,405 were not


Sen. Hatch on Amendment to Incentivize Generic Drug Development
  • Jones Day
  • USA
  • July 30 2018

As we reported in our July 2, 2018 article Hatch Bill: Restore Hatch-Waxman Balance; Limit Generics’ Access to PTAB, Senator Orrin Hatch (R-Utah), the


FDA Issues Final Guidance on Biosimilar Labeling, Sticking with Generic Model
  • Patterson Belknap Webb & Tyler LLP
  • USA
  • July 30 2018

Earlier this month, FDA issued final guidance on the labeling of biosimilar products. The final guidance continues the approach adopted in FDA’s March


Washington Healthcare Update - Jul 23, 2018
  • McGuireWoods LLP
  • USA
  • July 23 2018

The House of Representatives approved the first major change to federal regulation of the over-the-counter drug industry in 40 years. The bill, H.R


Online Pharmaceuticals - Not Much Online Liability
  • Reed Smith LLP
  • USA
  • July 9 2018

We’ve seen stories lately that an increasing trend towards online sales of prescription drugs could become as much of a threat to retail drugstores as


House Approves Sweeping Health Care Legislation
  • Mintz
  • USA
  • June 25 2018

On Tuesday, June 19, 2018, the Massachusetts House of Representatives passed comprehensive health care legislation by a vote of 117-32. The bill


Washington Healthcare Update - Jun 4, 2018
  • McGuireWoods LLP
  • USA
  • June 4 2018

In a series of interviews during the recess week, Senate Majority Leader Mitch McConnell has described what he expects the Senate to act on. McConnell


India: Impact of proposed EU IPR enforcement mechanism on the growth of Indian generic drugs
  • SS Rana & Co
  • India
  • June 4 2018

India is one of the largest suppliers of low cost generic medicines in the world. The use of generic medicines, in comparison with their branded